Villain, N., Planche, V., & Levy, R. (2022). High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects. Revue neurologique, 178(10), 1011-1030. https://doi.org/10.1016/j.neurol.2022.06.012
Chicago-Zitierstil (17. Ausg.)Villain, N., V. Planche, und R. Levy. "High-clearance Anti-amyloid Immunotherapies in Alzheimer's Disease. Part 1: Meta-analysis and Review of Efficacy and Safety Data, and Medico-economical Aspects." Revue Neurologique 178, no. 10 (2022): 1011-1030. https://doi.org/10.1016/j.neurol.2022.06.012.
MLA-Zitierstil (9. Ausg.)Villain, N., et al. "High-clearance Anti-amyloid Immunotherapies in Alzheimer's Disease. Part 1: Meta-analysis and Review of Efficacy and Safety Data, and Medico-economical Aspects." Revue Neurologique, vol. 178, no. 10, 2022, pp. 1011-1030, https://doi.org/10.1016/j.neurol.2022.06.012.